Product
Vazyme COVID-19
Research Solutions for Coronavirus – Vazyme
Vazyme Solutions for SARS-CoV-2 (2019-nCoV) Detection
Virus Sample Stabilizer (with Nasopharyngeal Swab)
Cat#
Size
Introduction
50 tubes, 3 ml / tube
Applicable to specimen collection from human nasopharyngeal swab
specimen and nucleic acid preservation.
Product
FastPure Viral DNA/RNA Mini Kit
Cat#
Size
Introduction
100 tests / kit
Applicable to specimen collection from plasma, serum, nasopharyngeal swabs, sputum, bronchoalveolar lavage fluid, ascites, supernatant of cultured cell and urine.
Product
2019-Novel Coronavirus (2019-nCoV) Triplex RT-qPCR Detection Kit
Cat#
Size
Introduction
100 tests / kit
1) Adding 20 ul of extracted RNA to increase detection sensitivity and reduce false negatives;
2) Positive control (2019-nCoV-pseudoviruse) provides a nucleic acid extraction and a reverse transcription control to validate the entire procedure and reagent integrity. 3) Internal control (RNAse P gene) provides a nucleic acid extraction procedural control and a secondary
negative control.
Product
2019-Novel Coronavirus (2019-nCoV) IgG / IgM Detection Kit (Colloidal Gold-Based)
Cat#
Size
Introduction
50 tests / kit
Applicable to detection of 2019-nCoV IgG / IgM antibodies from human whole blood, serum or plasma within 10 min. No instruments needed.
2019-nCoV IgG / IgM Detection Kit (Colloidal Gold-Based)
Rapid detection within 10 min. No equipments required.
Both IgM and IgG are immunoglobulin which are produced by the immune system to provide protection against the 2019-nCoV. Some patients with negative results in nucleic acid test show positive in IgM test, indicating that the IgG / IgM detection is one of the effective methods for the diagnosis of 2019-nCoV.
The level of IgM antibody begins to rise after 1 week after the initial infection, while the IgG appears later than IgM (usually in 14 days after infection) and can last for 6 months or even several years, which means that the IgG serves as an indicator of previous infection. Suspected patients that are infected by 2019-nCoV can be rapidly identified by simultaneous monitoring of IgM and IgG. During the outbreak period of 2003-SARS and the 2016-Zika, IgM / IgG antibody detection was used as one of the recommended diagnostic methods.
Product Advantages
- Rapid-screening within 10 minutes.
- High detection efficiency: simultaneous monitoring of IgM and IgG.
- Detection without any equipments.
- Easy to operate, and is compatible with serum/ whole blood/ plasma.
- Room-temperature storage.
Interpreting Test Results
| Results | Interpreting |
| IgM positive, IgG positive | Indicates that it may be a recent infection with 2019-nCoV. |
| IgM positive, IgG negative | Indicates that it may be a recent infection with 2019-nCoV. |
| IgM negative, IgG positive | Indicates that it may be a previous infection with 2019-nCoV. |
| IgM negative, IgG negative | Indicates that it may be on infection with 2019-nCoV, or there is not enough detectable antibodies in the early infection. |
| Product Name | 2019-nCoV IgG / IgM Detection Kit (Colloidal Gold-Based) |
| Size | 50 Tests / Kit |
| Specimen | Serum / Plasma / Whole Blood |
| Required Volume of Specimen | 20 ul |
| Storage | 4℃ - 30℃. Sealed. |
Your first choice for scientific solutions
Find out more
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations